《半新股》海吉亚医疗(06078.HK)逆市急涨14%再破顶 成交倍增
海吉亚医疗(06078.HK)连升第三天,今天股价再破顶,最高见53.9元,现造53.15元,逆市急涨14%,成交倍增至384万股,涉资1.95亿元。
海吉亚是内地最大肿瘤医疗集团。股份於今年6月尾以每股18.5元来港上市,集资净额约20.72亿元,主要用作升级现有医院和设立4间新医院及收购医院等。该股超额配股权获悉数行使,额外筹约3.2亿元。另外,公司上月下旬公布,中期纯利按年减逾81%至235.6万人民币,但总营收按年升近23%至6.32亿元人民币。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.